Anna Lynn Hoppmann, MD

Description

Keywords breast cancer immunotherapy, splenic sequestration, umbilical cord blood transplant, pediatric cancer, hemoglobinopathies, thrombocytosis, pure red cell aplasia, aplastic anemia, porphyria, cryoglobulinemia, cancer immunotherapy, blood disorders, lymphopenia, early detection of cancer, von willebrand disease, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), anaplastic cancer of thyroid, anemia of chronic disease, familial aplastic anemia, cooley anemia, pernicious anemia, hemolytic anemia, non hodgkin lymphoma, myeloproliferative diseases, langerhans cell histiocytosis, factor v leiden, bone marrow disorders, blood cancer, antithrombin deficiency, adverse effects to anticoagulants, pleomorphic xanthoastrocytomas, fanconi anemia, epithelioid hemangioendothelioma, diamond blackfan anemia, thrombophilia, thrombocytopenia, thalassemia, teratogen exposure, splenomegaly, sickle cell disease, severe congenital neutropenia, secondary polycythemia, rh incompatibility, purpura, polycythemia, plasma cell dyscrasia, peutz jeghers syndrome, petechiae, paroxysmal nocturnal hemoglobinuria, pancytopenia, neutropenia, myelodysplastic syndrome, lymphoma, li fraumeni syndrome, leukopenia, leukemia, iron deficiency anemia, idiopathic thrombocytopenic purpura, hypogammaglobulinemia, hypercoagulable state, heparin induced thrombocytopenia, hemophilia, hemolytic uremic syndrome, hemolytic disease of the fetus, hemochromatosis, hellp syndrome, factor nine deficiency, factor eight disorder, dyskeratosis congenita, chemoradiation, cancer genomics, adjuvant chemotherapy, biological targeted therapy, cancer chemotherapy, blood clotting disorder, bleeding disorder, b12 deficiency anemia, anemia, primary systemic amyloidosis.